论文部分内容阅读
据Andreoli E 2014年5月21日(J Mater Chem B,2014 May 21.)报道,美国莱斯大学的研究人员通过研究开发出了一种特殊定制的短碳纳米管,其或可以将药物运输之胰腺癌细胞中对癌细胞进行靶向杀灭作用。许多胰腺癌患者会在诊断后1年内死亡,而该病5年生存率也只有6%,当前并没有针对胰腺癌有效的早期诊断方法;胰腺癌通常不能通过手术来进行治疗,而且利用化学治疗方法也很难对胰腺癌细胞进行作用。研究人员开发了一种碳纳米管,其可以以其较小的尺寸顺利通过机体的防御系统成功达到胰腺癌细胞,对癌细胞实施攻击。
According to Andreoli E, May 21, 2014 (J Mater Chem B, 2014 May 21.), researchers at Rice University in the United States reported on the development of a specially tailored short carbon nanotube that can either transport the drug Of pancreatic cancer cells targeted killing effect on cancer cells. Many pancreatic cancer patients will die within 1 year after diagnosis, and the 5-year survival rate of the disease is only 6%. There is currently no effective early diagnosis for pancreatic cancer; pancreatic cancer can not usually be treated by surgery, and the use of chemotherapy Method is also difficult to pancreatic cancer cells. Researchers have developed a carbon nanotube that can successfully reach pancreatic cancer cells through its body’s defense system in its smaller size and attack cancer cells.